Cargando…
Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
Previous research has determined that the required doses for treating febrile neutropenia with vancomycin are higher than the doses used conventionally. These recommendations have been made considering pharmacotherapeutic goals based on minimum concentration ([Formula: see text]) between 15–20 [Form...
Autores principales: | Parra González, Daniel, Pérez Mesa, Jefferson Alejandro, Cuervo Maldonado, Sonia Isabel, Díaz Rojas, Jorge Augusto, Cortés, Jorge Alberto, Silva Gómez, Edelberto, Saavedra Trujillo, Carlos Humberto, Gómez, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686913/ https://www.ncbi.nlm.nih.gov/pubmed/36358178 http://dx.doi.org/10.3390/antibiotics11111523 |
Ejemplares similares
-
Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021) -
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013) -
394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014) -
Best Practices in the Management of Infectious Complications for Patients With Cancer: Management of Febrile Neutropenia
por: Molina, Kyle C.
Publicado: (2023) -
2676. Effect of β-Lactam Allergy on Appropriateness of Antibiotic Use in Patients with Febrile Neutropenia
por: Yetmar, Zachary A, et al.
Publicado: (2019)